Loading...
XSHE
002435
Market cap62mUSD
Jul 01, Last price  
0.37CNY
Name

ChangjiangRunfa Health Industry Co Ltd

Chart & Performance

D1W1MN
P/E
—
P/S
0.14
EPS
—
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
-7.08%
Revenues
3.24b
-6.67%
596,205,942894,547,877748,500,982839,494,0611,119,745,9571,174,507,2681,154,844,2741,227,882,2181,064,708,5092,115,003,5382,986,947,6004,673,757,0335,038,467,4834,240,584,1774,369,815,1253,469,557,8313,238,105,676
Net income
0k
-100.00%
38,309,64137,360,21243,168,42941,713,67846,040,03742,425,30351,589,40148,126,96343,673,281160,147,985334,693,598367,129,5500247,690,345041,333,1980
CFO
339m
-35.23%
19,991,61576,833,11873,765,885115,366,7940189,119,5632,234,91642,024,18510,575,533637,941,764483,064,874286,938,465374,325,211383,327,304294,312,912523,058,080338,785,649
Dividend
Jun 18, 20210.05 CNY/sh
Earnings
May 28, 2025

Profile

Changjiang Runfa Health Industry Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China and internationally. It also provides specialized medical services for obstetrics and gynecology; and sells mechanical products, such as elevator guide rails. The company was founded in 1989 and is based in Zhangjiagang, China.
URL
http://cjjkcy.com/
IPO date
Jun 18, 2010
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
3,238,106
-6.67%
3,469,558
-20.60%
Cost of revenue
3,128,289
3,155,364
Unusual Expense (Income)
NOPBT
109,816
314,194
NOPBT Margin
3.39%
9.06%
Operating Taxes
24,310
25,044
Tax Rate
22.14%
7.97%
NOPAT
85,506
289,150
Net income
41,333
 
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
1,877,799
1,550,831
Long-term debt
649,946
450,689
Deferred revenue
17,378
10,384
Other long-term liabilities
172,529
140,173
Net debt
(20,357)
(516,379)
Cash flow
Cash from operating activities
338,786
523,058
CAPEX
Cash from investing activities
Cash from financing activities
734,959
488,151
FCF
385,277
730,503
Balance
Cash
2,691,357
2,517,900
Long term investments
(143,255)
Excess cash
2,386,197
2,344,422
Stockholders' equity
1,275,333
1,411,389
Invested Capital
5,088,386
5,218,028
ROIC
1.66%
5.81%
ROCE
1.71%
4.73%
EV
Common stock shares outstanding
1,236,061
1,235,983
Price
4.17
-10.71%
4.67
-11.39%
Market cap
5,154,375
-10.70%
5,772,041
-11.39%
EV
5,172,692
5,339,359
EBITDA
294,019
462,669
EV/EBITDA
17.59
11.54
Interest
92,231
73,927
Interest/NOPBT
83.99%
23.53%